Literature DB >> 336988

Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.

N S Brewer.   

Abstract

Aminoglycoside antibiotics are poorly absorbed from the gastrointestinal tract, do not penetrate well into the cerebrospinal fluid, are minimally bound to plasma proteins, and are rapidly excreted by the normal kidney. Neomycin is limited by its toxicity to irrigating and topical preparations or to oral medication for surgical bowel preparations or hepatic coma. Streptomycin has only a few specific indications, because newer agents are available that have broader spectrums of activity. Kanamycin is indicated in serious gram-negative infections in which Pseudomonas aeruginosa is not a likely causative agent. Gentamicin, tobramycin, and amikacin are effective against a broad spectrum of gram-negative organisms including P. aeruginosa. In general, both gentamicin and tobramycin are more active in vitro than amikacin on a weight basis; however, higher serum levels are achievable with amikacin than with the two others. Amikacin is probably the aminoglycoside of first choice when gentamicin resistance is strongly suspected.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336988

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli.

Authors:  A S Bayer; A W Chow; J O Morrison; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

2.  Complex calcium carbonate/polymer microparticles as carriers for aminoglycoside antibiotics.

Authors:  Stefania Racovita; Ana-Lavinia Vasiliu; Adrian Bele; Dana Schwarz; Christine Steinbach; Regine Boldt; Simona Schwarz; Marcela Mihai
Journal:  RSC Adv       Date:  2018-06-27       Impact factor: 4.036

3.  Design, synthesis, and discovery of novel oxindoles bearing 3-heterocycles as species-specific and combinatorial agents in eradicating Staphylococcus species.

Authors:  Jonghoon Shin; Krishna Bahadur Somai Magar; Jungwoon Lee; Kwang-Sun Kim; Yong Rok Lee
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.